Gapping down
In reaction to earnings/guidance:
- RMNI -27.9%, UPLD -25.9%, LSPD -19.1%, SPWR -11.1%, LCI -10.9% (also announces restructuring plan), MRNA -10.8%, MTW -10.1%, MGNI -9.4%, QRVO -9.3% (also acquires United Silicon Carbide), QUOT -9.2%, MDU -9%, TNDM -8.8%, ELF -8.8%, SKLZ -8.2%, DOCN -8%, NEO -7.6%, ROKU -7.4%, CLR -7.3% (also to acquire Permian Basin assets from PXD for $3.25 bln), QRTEA -7.2%, RCII -6.4%, TPC -6.1%, MTTR -5.9%, WHD -5.7%, FIS -5.3%, BLL -5.1%, PENN -5%, COMM -4.8%, W -4.8%, BBIO -4.7%, CDAY -4.5%, SWM -4.4%, GPRE -4.3%, TRUP -3.7%, ALL -3.7%, LITE -3.6%, DLX -3.5%, VNDA -3.3%, LXP -3.3%, STRA -2.9%, NRG -2.8%, FSR -2.4%, VVV -2.4%, APTV -2.4%, KTOS -2.3%, ALE -2.2%, REGI -2.1%, STAA -2.1%, LNC -2.1%, APD -2.1%, DISH -2%, CTXS -1.9%, BLI -1.8%, WMS -1.8%, RVLV -1.7%, EQIX -1.7%, RGR -1.6%, AES -1.6%, CF -1.5%, CF -1.5%, HWM -1.5%, IRWD -1.5%, INSG -1.4%, OSUR -1.3%, SJI -1.3%, ITT -1.3%, GOLF -1.3%, PLMR -1.2%, AEE -1.2%, SLF -1.2%, VNT -1.2%, CCOI -1.2%, REYN -1.2%, PWR -1.1%, NTCT -1.1%, GTN -1%, DEN -1%, VMC -1%
Other news:
- CMRX -26.9% (topline data from its 50-patient efficacy analysis of ONC201)
- ANIP -6.6% (prices offering of 1.5 mln shares of common stock at $50.00 per share)
- FIS -5.8% (announces updated capital allocation strategy; increases expected annual dividend growth rate)
- STAG -2.9% (prices offering of 8 mln shares of common stock for gross proceeds of $340 mln)
- APTO -2% (entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239)
- FRBK -1% (receives letters from Driver Management)
Analyst comments:
- ASAN -2.6% (downgraded to Hold from Buy at Jefferies)
- AMRC -1.8% (downgraded to Neutral from Overweight at Piper Sandler)